Ausgabe 1/2007
Inhalt (13 Artikel)
Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications
Reinou S. Groen, A. Wolter J. Oosterhuis, James E. Boers
RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer
Y. S. Lau, L. Danks, S. G. Sun, S. Fox, A. Sabokbar, A. Harris, N. A. Athanasou
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer
Hope Rugo, Emma Shtivelman, Alejandra Perez, Charles Vogel, Sandra Franco, Elizabeth Tan Chiu, Michelle Melisko, Mary Tagliaferri, Isaac Cohen, Mark Shoemaker, Zung Tran, Debu Tripathy
Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells
John Yoonkeun Jun, James W. Griffith, Richard Bruggeman, Sharlene Washington, Laurence M. Demers, Michael F. Verderame, Andrea Manni
Minority report – false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis
S. Ciatto, N. Houssami, D. Ambrogetti, R. Bonardi, G. Collini, M. Rosselli Del Turco
Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors
Page E. Abrahamson, Shelley S. Tworoger, Erin J. Aiello, Leslie Bernstein, Cornelia M. Ulrich, Frank D. Gilliland, Frank Z. Stanczyk, Richard Baumgartner, Kathy Baumgartner, Bess Sorensen, Rachel Ballard-Barbash, Anne McTiernan
Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival
Aesun Shin, Zefang Ren, Xiao-Ou Shu, Qiuyin Cai, Yu-Tang Gao, Wei Zheng
Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer
N. van den Broek, M. J. C. van der Sangen, L. V. van de Poll-Franse, M. W. P. M. van Beek, G. A. P. Nieuwenhuijzen, A. C. Voogd
Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study
Jane C. Figueiredo, Marguerite Ennis, Julia A. Knight, John R. McLaughlin, Nicky Hood, Frances O’Malley, Irene L. Andrulis, Pamela J. Goodwin
Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature
Alberto Luini, Giovanna Gatti, Jack Diaz, Edoardo Botteri, Eliegina Oliveira, Rafaela Cecilio Sahium de Almeida, Paolo Veronesi, Mattia Intra, Gianmatteo Pagani, Paola Naninato, Giuseppe Viale
Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)
Jennifer M. Specht, Stephen L. Tam, Brenda F. Kurland, Julie R. Gralow, Robert B. Livingston, Hannah M. Linden, Georgiana K. Ellis, Erin K. Schubert, Lisa K. Dunnwald, David A. Mankoff
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro
E. Bucciarelli, A. Sidoni, G. Bellezza, A. Cavaliere, G. Brachelente, G. Costa, M. Chaplet, V. Castronovo, A. Bellahcène
Mid-region parathyroid hormone-related protein (PTHrP) binds chromatin of MDA-MB231 breast cancer cells and isolated oligonucleotides “in vitro”
Rosalia Sirchia, Marcella Priulla, Giulia Sciandrello, Fabio Caradonna, Giuseppa Barbata, Claudio Luparello